IPUBLIC RECORDSEXCHANGERECEIPTSloadinglive·IMONEY TRAILEXCHANGESOURCESverifyinglive·IDATA SOURCESEXCHANGEFILINGSpublic recordslive·IPUBLIC RECORDSEXCHANGERECEIPTSloadinglive·IMONEY TRAILEXCHANGESOURCESverifyinglive·IDATA SOURCESEXCHANGEFILINGSpublic recordslive·
FEDERAL LOBBYING RECORDS

LOBBYING FILINGS AND MARKET CONTEXT

Indexed federal lobbying filings mapped to clients, registrants, and public-company tickers. Transaction dates are compared with filing periods to identify date-proximity review flags. Proximity does not establish coordination, influence, or wrongdoing.

Filings tracked
20,641
thru 2026-07-15
Total reported $
$2.7B
disclosed lobbying
Distinct clients
2,260
paying companies
Tickers targeted
1,219
public companies

Clients by reported amount

#ClientFilingsTotal $
1PFIZER INC.PFE48$46.9M
2GENERAL MOTORS COMPANYGM61$46.8M
3META PLATFORMS INC. AND VARIOUS SUBSIDIARIESMETA13$45.0M
4VISA INC.V46$37.7M
5AMAZON.COM SERVICES LLCAMZN37$32.8M
6LOCKHEED MARTIN CORPORATIONLMT76$29.1M
7FEDEX CORPORATIONFDXW71$27.9M
8ELI LILLY AND COMPANYLLY60$27.4M
9ALTRIA CLIENT SERVICES LLCMO147$25.3M
10COMCAST CORPORATIONCMCSV183$24.9M
11AMGEN INCAMGN19$24.9M
12MERCK & CO INCMRK14$24.0M
13SOUTHERN COMPANYSO54$23.9M
14GOOGLE CLIENT SERVICES LLCGOOGL83$22.8M
15APPLE INCAAPL9$22.1M
16T-MOBILE USA INC.TMUS131$21.3M
17UNITEDHEALTH GROUP INCUNH19$20.4M
18VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIESVZ41$20.1M
19OCCIDENTAL PETROLEUM CORPORATIONOXY32$19.8M
20MICROSOFT CORPORATIONMSFT107$18.9M
21QUALCOMM INCORPORATEDQCOM40$17.2M
22BOEING COMPANYBA24$17.0M
23GENERAL DYNAMICS CORPGD11$17.0M
24THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)CI13$16.9M
25ORACLE CORPORATIONORCL60$16.8M

Mapped tickers by reported amount

#TickerFilingsTotal $
1META
Meta Platforms Inc.
134$50.3M
2PFE
Pfizer Inc.
89$48.7M
3GM
General Motors Company
103$48.4M
4V
Visa Inc.
47$37.7M
5AMZN
Amazon.com Inc.
82$35.4M
6LMT
Lockheed Martin Corporation
92$29.5M
7FDX
FedEx Corporation
83$28.4M
8LLY
Eli Lilly and Company
88$28.4M
9AMGN
Amgen Inc.
100$28.0M
10MRK
Merck & Co. Inc.
92$27.5M
11AAPL
Apple Inc.
66$27.0M
12GOOGL
Alphabet Inc. Class A
128$26.8M
13MO172$26.4M
14SO
Southern Company
110$26.2M
15UNH
UnitedHealth Group Inc.
68$24.0M
16VZ
Verizon Communications Inc.
119$23.8M
17TMUS170$22.9M
18CHTR142$22.8M
19GD
General Dynamics Corporation
131$22.6M
20T
AT&T Inc.
137$21.7M
21ORCL
Oracle Corporation
135$20.8M
22CMCSA
Comcast Corporation
142$20.5M
23OXY
Occidental Petroleum Corporation
38$20.1M
24CI
The Cigna Group
64$19.9M
25MSFT
Microsoft Corporation
126$19.3M

🆕 Filtered Filings · REGENERON PHARMACEUTICALS INC.

clear filters
DateTickerClientRegistrantAmountIssue
2026-07-15REGNREGENERON PHARMACEUTICALS INC.CHECKMATE GOVERNMENT RELATIONS$90KThere is no current bill filed. Engagement with HHS regarding issues related to healthcare.
2026-07-08REGNREGENERON PHARMACEUTICALS INC.THE WASHINGTON TAX & PUBLIC POLICY GROUP$30KIssues related to corporate and international taxation. Issues related to OECD Pillar 1 and Pillar 2 negotiations, agreements, implementation, and reporting related to the taxation of global income. Issues related to IRC sections 11, 951A, and 250.
2026-05-04REGNREGENERON PHARMACEUTICALS INC.CRANE STRATEGIES$50KBiodefense and Medicare prescription drug funding
2026-04-20REGNREGENERON PHARMACEUTICALS INC.BGR GOVERNMENT AFFAIRS$90KProvide strategic counsel and advocate on issues related to matters of importance to domestic pharmaceutical manufacturers
2026-04-20REGNREGENERON PHARMACEUTICALS INC.ARNOLD & PORTER KAYE SCHOLER LLP$0Outreach related to FY 2027 appropriations. Outreach related to FY 2027 appropriations.
2026-04-15REGNREGENERON PHARMACEUTICALS INC.CHECKMATE GOVERNMENT RELATIONS$90KThere is no current bill filed. Engagement with HHS regarding issues related to healthcare.
2026-04-01REGNREGENERON PHARMACEUTICALS INC.THE WASHINGTON TAX & PUBLIC POLICY GROUP$30KIssues related to corporate and international taxation. Issues related to OECD Pillar 2 negotiations and agreements on the taxation of global income. Issues related to IRC sections 11, 951A, 250, and 174.
2026-01-21REGNREGENERON PHARMACEUTICALS INC.CRANE STRATEGIES$50KBiodefense funding
2026-01-20REGNREGENERON PHARMACEUTICALS INC.CHECKMATE GOVERNMENT RELATIONS$90KThere is no current bill filed. Engagement with HHS regarding issues related to healthcare.
2026-01-20REGNREGENERON PHARMACEUTICALS INC.BGR GOVERNMENT AFFAIRS$90KProvide strategic counsel and advocate on issues related to matters of importance to domestic pharmaceutical manufacturers
2026-01-16REGNREGENERON PHARMACEUTICALS INC.THE WASHINGTON TAX & PUBLIC POLICY GROUP$30KIssues related to corporate and international taxation. Issues related to OECD Pillar 2 negotiations and agreements on the taxation of global income. Issues related to IRC sections 11, 951A, 250, and 174. (H.R. 1990, S. 1649, H.R. 1 - Sections - 70321, 70322, 70323, 70302)
2026-01-16REGNREGENERON PHARMACEUTICALS INC.ARNOLD & PORTER KAYE SCHOLER LLP$0
2025-10-20REGNREGENERON PHARMACEUTICALS INC.CHECKMATE GOVERNMENT RELATIONS$90KThere is no current bill filed. Engagement with HHS regarding issues related to healthcare.
2025-10-20REGNREGENERON PHARMACEUTICALS INC.BGR GOVERNMENT AFFAIRS$90KProvide strategic counsel and advocate on issues related to matters of importance to domestic pharmaceutical manufacturers
2025-10-16REGNREGENERON PHARMACEUTICALS INC.ARNOLD & PORTER KAYE SCHOLER LLP$0
2025-10-14REGNREGENERON PHARMACEUTICALS INC.THE WASHINGTON TAX & PUBLIC POLICY GROUP$30KIssues related to corporate and international taxation. Issues related to OECD Pillar 2 negotiations and agreements on the taxation of global income. Issues related to IRC sections 11, 951A, 250, 162(m), and 174. (H.R. 1990, S. 1649, H.R. 1 - Sections - 70321, 70322, 70323, 70302, 70604)
2025-10-01REGNREGENERON PHARMACEUTICALS INC.CRANE STRATEGIES$50KBiodefense funding
2025-07-21REGNREGENERON PHARMACEUTICALS INC.BGR GOVERNMENT AFFAIRS$90KProvide strategic counsel and advocate on issues related to matters of importance to domestic pharmaceutical manufacturers
2025-07-20REGNREGENERON PHARMACEUTICALS INC.CHECKMATE GOVERNMENT RELATIONS$90KThere is no current bill filed. Engagement with HHS regarding issues related to healthcare.
2025-07-17REGNREGENERON PHARMACEUTICALS INC.ARNOLD & PORTER KAYE SCHOLER LLP$0
2025-07-11REGNREGENERON PHARMACEUTICALS INC.THE WASHINGTON TAX & PUBLIC POLICY GROUP (FORMERLY THE WASHINGTON TAX GROUP)$30KIssues related to corporate and international taxation. Issues related to OECD Pillar 2 negotiations and agreements on the taxation of global income. Issues related to IRC sections 11, 951A, 250, 162(m), and 174. (H.R. 1990, S. 1649, H.R. 1 - Sections - 70321, 70322, 70323, 70302, 70604)
2025-07-10REGNREGENERON PHARMACEUTICALS INC.BGR GOVERNMENT AFFAIRS$0Provide strategic counsel and advocate on issues related to matters of importance to domestic pharmaceutical manufacturers
2025-07-01REGNREGENERON PHARMACEUTICALS INC.CRANE STRATEGIES$50KBiodefense funding
2025-05-05REGNREGENERON PHARMACEUTICALS INC.CRANE STRATEGIES$50KBiodefense funding
2025-04-21REGNREGENERON PHARMACEUTICALS INC.STEWART STRATEGIES AND SOLUTIONS, LLC$60K
2025-04-21REGNREGENERON PHARMACEUTICALS INC.CHECKMATE GOVERNMENT RELATIONS$30KThere is no current bill filed. Engagement with HHS regarding issues related to healthcare.
2025-04-21REGNREGENERON PHARMACEUTICALS INC.ARNOLD & PORTER KAYE SCHOLER LLP$0
2025-04-17REGNREGENERON PHARMACEUTICALS INC.THE WASHINGTON TAX & PUBLIC POLICY GROUP$30KIssues related to corporate and international taxation. Issues related to OECD Pillar 2 negotiations and agreements on the taxation of global income. Issues related to IRC sections 11, 951A, 250, 162(m), 174 and 41. (H.R. 1990)
2025-03-27REGNREGENERON PHARMACEUTICALS INC.CHECKMATE GOVERNMENT RELATIONS$0Issues related to healthcare.
2025-02-07REGNREGENERON PHARMACEUTICALS INC.THE WASHINGTON TAX & PUBLIC POLICY GROUP$0Issues related to corporate and international tax
2025-01-21REGNREGENERON PHARMACEUTICALS INC.STEWART STRATEGIES AND SOLUTIONS, LLC$60K